Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.23 CAD -4.44% Market Closed
Market Cap: 88.5m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Covalon Technologies Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Additional Paid In Capital
CA$11.8m
CAGR 3-Years
0%
CAGR 5-Years
12%
CAGR 10-Years
18%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Additional Paid In Capital
$24.6m
CAGR 3-Years
25%
CAGR 5-Years
21%
CAGR 10-Years
12%
ESSA Pharma Inc
NASDAQ:EPIX
Additional Paid In Capital
$54.8m
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Additional Paid In Capital
$119.8m
CAGR 3-Years
30%
CAGR 5-Years
33%
CAGR 10-Years
26%
Spectral Medical Inc
TSX:EDT
Additional Paid In Capital
CA$10.1m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
2%
No Stocks Found

Covalon Technologies Ltd
Glance View

Market Cap
88.5m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.73 CAD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Covalon Technologies Ltd's Additional Paid In Capital?
Additional Paid In Capital
11.8m CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Additional Paid In Capital amounts to 11.8m CAD.

What is Covalon Technologies Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
18%

Over the last year, the Additional Paid In Capital growth was 4%.

Back to Top